Vallone

Hightop Health Adds Industry Veteran to Board of Directors

Retrieved on: 
Thursday, December 14, 2023
Mental Health, Health, Practice Management, Health Technology, Managed Care, High-top, Mass General Brigham, Acquisition, Mass, Multimedia, Patient, News, Trustee, Vallone, Harvard Medical School, Partnership, McLean Hospital, MGB, Management, Nursing

Hightop Health , a premier outpatient mental health platform, today announced the appointment of Carol Vallone as its Independent Board Director.

Key Points: 
  • Hightop Health , a premier outpatient mental health platform, today announced the appointment of Carol Vallone as its Independent Board Director.
  • View the full release here: https://www.businesswire.com/news/home/20231214543962/en/
    Carol Vallone, seasoned CEO and McLean Hospital Board Chair, was today announced as Hightop Health's first Independent Board Director.
  • With its launch, Hightop aimed to gather the best minds in the industry to speak into Hightop’s strategy and approach, including a Board of Directors and Clinical Advisory Board, with Carol Vallone being its first Independent Board Director.
  • Her work and partnership with clinical leaders paired with her understanding of the behavioral health industry lends itself to furthering the Hightop mission.

Bio Recovery Group, a Leading Crime Scene Cleanup Company, Becomes Woman-Owned Business and Names New CEO

Retrieved on: 
Monday, December 4, 2023
Titan, Bio Recovery Corporation, Safety, Alec Baldwin, Fashion Institute of Technology, Vallone, Trauma, J.Crew, Crime, Portland Fashion Institute

CALVERTON, N.Y., Dec. 4, 2023 /PRNewswire/ -- Bio Recovery Group LLC, a leading biohazard cleanup company, today announced that Victoria Vallone, 29, has become its Managing Member and has been named its Chief Executive Officer.

Key Points: 
  • Recent cleanups include the Titan Titanic submersible and the fatal shooting on the set of the Alec Baldwin film Rust.
  • Vallone, a graduate of the Fashion Institute of Technology, joined Bio Recovery in 2017 as a Crime Scene Cleanup Technician upon leaving her previous position in the production department of J.
  • Vallone said, "I am very proud to acquire control of Bio Recovery and become its CEO to continue our important work and accelerate our national expansion.
  • Bio Recovery Group LLC, a woman-owned business, is a leading biohazard cleanup company committed to providing prompt, compassionate, and professional services.

Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees

Retrieved on: 
Monday, June 5, 2023
Finance, Neurology, Public Relations, Investor Relations, Banking, Clinical Trials, Communications, Professional Services, Biotechnology, Pharmaceutical, Health, MindMed, Bruhn, Drug development, NOT, ALL, Medicine, AGM, University Hospital of Basel, Teaching hospital, Annual general meeting, Collection, Patient, Financial management, Mental health, NEO, ISS, FCM, Security (finance), Risk management, Management, Crystal, Vallone

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), (the “Company” or “MindMed”) today announced that leading proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) has recommended shareholders vote for ALL of MindMed’s six highly qualified director nominees at the upcoming Annual Meeting of Shareholders (“Annual Meeting”), scheduled for June 15, 2023.

Key Points: 
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), (the “Company” or “MindMed”) today announced that leading proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) has recommended shareholders vote for ALL of MindMed’s six highly qualified director nominees at the upcoming Annual Meeting of Shareholders (“Annual Meeting”), scheduled for June 15, 2023.
  • MindMed encourages all shareholders to follow the recommendation of ISS and vote "FOR" the Company's six highly qualified director nominees using the WHITE universal proxy card at the upcoming Annual Meeting, scheduled for June 15, 2023.
  • Vote TODAY on the WHITE proxy card FOR all six of the Board’s nominees, WITHHOLD on FCM’s nominees and FOR the other proposals recommended by your Board.
  • Shareholders will receive proxy materials directly via the preferred method, hard copy or email, specific to each shareholder’s account.

Cresco Labs Announces Appointment of Carol Vallone to its Board and the Retirement of Brian McCormack

Retrieved on: 
Thursday, July 30, 2020
Alternative medicine, Health, Retail, Tobacco, Specialty, Cannabis, Cannabis in Illinois, Cresco Labs, Cresco, Vallone

View the full release here: https://www.businesswire.com/news/home/20200730005170/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200730005170/en/
    Cresco Labs announced the appointment of well-known business leader Carol Vallone to its board of directors (Photo: Business Wire)
    Cresco has appointed Carol Vallone to its board of directors, effective immediately.
  • The Company today announced that Brian McCormack, Vice Chairman of the board, has retired from the Companys board of directors as part of the planned board refreshment process.
  • Tom Manning, Cresco Labs Executive Chairman, added, I also want to recognize Brian for his early contributions and his vision.
  • While we will miss him, Im thrilled to welcome a powerful new voice, Carol Vallone, to the board.